Smiths Medical Acquires Zhejiang Zheda Medical Instrument
This article was originally published in PharmAsia News
Executive Summary
Smiths Medical, part of Smiths Group plc, has acquired Zhejiang Zheda Medical Instrument, which enjoys China's largest market share of medical infusion pumps. The move shows Smiths Medical's continued confidence and commitment in the country following the establishment of its China headquarters last year. With independent intellectual property rights and patents for medical infusion pumps, Zhejiang Zheda passed TUV Rhine's CE certificate in 2005. It subsequently entered the European market and its export growth rate exceeded 200 percent in the following two years. Besides maintaining Zhejiang Zheda's existing products and services, Smiths Medical says it will develop more products to cater to the requirements of global and local markets. (Click here for more - Chinese Language)